论文部分内容阅读
用 COX 模型,回顾性计量分析621例用导管灌注栓塞治疗的不能切除的晚期肝癌患者的预后因素。结果显示最有意义的预后因素是肿瘤大小和门静脉癌栓。1,3,5年总生存率为62.23%,12.85%和7.45%。中位存活时间为16.23月。论文结果提示对晚期肝癌最有效的治疗是栓塞治疗。有关预后因素的知识有益于患者选择治疗。
The COX model was used to retrospectively analyze the prognostic factors of 621 patients with unresectable advanced hepatocellular carcinoma treated with catheter infusion embolization. The results showed that the most significant prognostic factors were tumor size and portal vein tumor emboli. The 1, 3, and 5-year overall survival rates were 62.23%, 12.85%, and 7.45%. The median survival time was 16.23 months. The results of the paper suggest that the most effective treatment for advanced liver cancer is embolization. Knowledge about prognostic factors is beneficial to the patient’s choice of treatment.